PRospective Observational Study of perioperative OXygen administration (PROSOX) in patients undergoing major non-cardiac surgery under general anaesthesia in Australia and New Zealand.

The Alfred Hospital0 个研究点目标入组 150 人开始时间: 2020年10月7日最近更新: 2022年8月9日

适应症

试验速览

暂无简介。

•The anaesthesia events of participating anaesthetists will be eligible for inclusion if all of the following inclusion criteria are met:
•1.Patient at least 18 years of age, ASA 3 or 4
•2.Non-cardiac surgery performed under general anaesthesia
•3.Expected surgical duration of at least 120 minutes and an anticipated postoperative in hospital stay of at least one night

•The anaesthesia event will be excluded if any of the following exclusion criteria are met:
•1.Patient is pregnant or receiving supplemental oxygen immediately prior to surgery
•2.Site primary investigator view that there exists an indication for or contraindication to specified intraoperative oxygen therapy, which may include but is not limited to severe COPD, previous bleomycin or cisplatin chemotherapy, surgical procedures with a risk of airway fire, and thoracic surgery
•3.A prior anaesthesia event already recruited from the individual anaesthetist providing patient care in this study

发起方

The Alfred Hospital